NFKB1 and colonic neoplasm: Consistent with this role, MD2 blockade by L6H21, MD2 knockdown, and MD2 neutralizing antibody also reduced NF-κB activation and suppressed expression of proinflammatory molecules in colon cancer cells and tissues.